Ablatherm's effectiveness confirmed when radiotherapy fails

Recent publications and presentations to medical congresses show that more and more frequently, Ablatherm is obtaining excellent results in treating patients for whom radiotherapy has failed. In the past, these patients were unable to benefit from a second treatment, which was very difficult, or even impossible, after radiation therapy. Patients who are part of the best indications are obtaining nearly 85% favourable results.